Chambers Michael Andrew - Insider Non-Derivative Transactions at Sarepta Therapeutics, Inc. (SRPT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 16, 2024, Chambers Michael Andrew's relationship to Sarepta Therapeutics, Inc. (SRPT) is Director, and currently has 284,034 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SRPT insiders.
Data Source: SEC.
Chambers Michael Andrew - Insider Non-Derivative Transactions of SRPT Common Stock
Chambers Michael Andrew - Insider Non-Derivative Transactions at SRPT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 17, 2024 | P -- (Common Stock) | 13106 | 133.07 | 260102 |
| Aug 17, 2024 | P -- (Common Stock) | 18284 | 134.06 | 278386 |
| Aug 17, 2024 | P -- (Common Stock) | 5648 | 134.66 | 284034 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 1846 | 0 | 8277 |
| Aug 15, 2023 | P -- (Common Stock) | 5947 | 109.19 | 242964 |
| Aug 15, 2023 | P -- (Common Stock) | 4032 | 109.89 | 246996 |
| Aug 12, 2023 | P -- (Common Stock) | 23686 | 108.05 | 237017 |
| Aug 11, 2023 | P -- (Common Stock) | 2206 | 104.67 | 180670 |
| Aug 11, 2023 | P -- (Common Stock) | 1091 | 105.9 | 181761 |
| Aug 11, 2023 | P -- (Common Stock) | 31570 | 106.26 | 213331 |
| Mar 7, 2023 | Acquisition -- (Common Stock) | 1523 | 0 | 6431 |